In vitro and in vivo analysis of monotherapy and dual therapy with ethyl caffeate and fluconazole on virulence factors of Candida albicans and systemic candidiasis
ABSTRACT: Objectives: Candida albicans is the most clinically prevalent cause of systemic fungal infections in the immunocompromised population. The biofilm-forming ability of C. albicans confers resistance to conventional antifungal agents. The main aim of this study was to investigate the antifun...
Guardado en:
Autores principales: | Tianming Wang, Min Pan, Nan Xiao, Jiadi Wu, Qirui Wang, Ting Cheng, Guiming Yan, Daqiang Wu, Ning Li, Jing Shao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bad0a52127a34d07bb28cac1abc3455d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antifungal Effects and Potential Mechanisms of Benserazide Hydrochloride Alone and in Combination with Fluconazole Against Candida albicans
por: Chen X, et al.
Publicado: (2021) -
Susceptibilidad antifúngica de Candida albicans recuperadas de pacientes con SIDA y candidiasis orofaríngea y esofágica: Experiencia con Etest®
por: Tapia P,Cecilia, et al.
Publicado: (2003) -
Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic <italic toggle="yes">Candida</italic> Species
por: Nicole M. Revie, et al.
Publicado: (2020) -
Adaptive Mistranslation Accelerates the Evolution of Fluconazole Resistance and Induces Major Genomic and Gene Expression Alterations in <named-content content-type="genus-species">Candida albicans</named-content>
por: Tobias Weil, et al.
Publicado: (2017) -
Natural Variation in Clinical Isolates of <named-content content-type="genus-species">Candida albicans</named-content> Modulates Neutrophil Responses
por: Madhu Shankar, et al.
Publicado: (2020)